EPRX Eupraxia Pharma Yalpi foyda normasi

Eupraxia Pharmaceuticals (EPRX) kompaniyasining rasmiy ramzlari

Eupraxia Pharmaceuticals (EPRX) yallig'lanishni davolash uchun mo'ljallangan DiffuX tizimi orqali uzoq muddatli ta'sirga ega dori vositalari segmentidagi ishtirokini kengaytirmoqda. Operatsion yalpi foyda marjasi investitsiya qilingan kapital zichligini aks ettiradi va ayni paytda ushbu ko'rsatkich 0.00 ni tashkil etmoqda. Sinovlarni tashqi pudratchilarga topshirish orqali jamoaning moslashuvchanligi saqlanmoqda, injeksiya ishlab chiqarishi esa yangi testlarni amalga oshirish uchun kengayayotgan sertifikatlangan CMO imkoniyatlariga tayanadi.

Eupraxia Pharmaceuticals (EPRX) Yalpi foyda bo'yicha rentabellik: 06.04.2024 - 20.11.2026 davri uchun

Eupraxia Pharmaceuticals Inc. (EPRX) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:eupraxiapharma.com (EPRX)
eupraxiapharma.com seriyali mahsuloti

Yalpi marja bevosita xarajatlarni chegirib tashlagandan keyingi foyda ulushini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi va bu biznesning pul oqimini yaratish bo'yicha fundamental qobiliyatini baholash imkonini beradi. Eupraxia Pharmaceuticals (EPRX) ning yalpi marja taqsimotini tahlil qilish orqali investor tadqiqot va ishlanmalar (R&D) hamda polimer mikrosfera xarajatlari qanchalik muvaffaqiyatli bozor qiymatiga aylantirilayotganini ko'rishi mumkin, bu esa biofarmatsevtika startapining barqarorligini baholash uchun juda muhimdir.

Asosiy raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|BHST (bioharvest.com) - Yalpi marja|Sotuvning yalpi rentabelligi EXOZ (invizyne.com)|Yalpi marja ORMP|Yalpi foyda bo'yicha sotuv rentabelligi Entera Bio|Yalpi marja HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Yalpi rentabellik|Cumberland Corp - Yalpi marja|QNTM - Yalpi marja|FibroGen, Inc. (FGEN) - Yalpi rentabellik|TELO: Yalpi foyda koeffitsiyenti|RANI (Rani Therapeutics Inc) - Yalpi marja|Yalpi foyda marjasi synergychc.com SNYR|Yalpi rentabellik Rallybio Corp. (RLYB)|LEXX - Yalpi foyda marjasi|Yalpi marja PULM (pulmatrix.com)|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja